Probi AB Stock

Equities

PROB

SE0001280355

Pharmaceuticals

Market Closed - Nasdaq Stockholm 08:52:03 2024-04-19 am EDT 5-day change 1st Jan Change
207 SEK -6.33% Intraday chart for Probi AB -4.17% +1.97%
Sales 2024 * 662M 60.64M Sales 2025 * 708M 64.85M Capitalization 2.36B 216M
Net income 2024 * 18M 1.65M Net income 2025 * 38M 3.48M EV / Sales 2024 * 3.02 x
Net cash position 2024 * 358M 32.79M Net cash position 2025 * 401M 36.73M EV / Sales 2025 * 2.76 x
P/E ratio 2024 *
125 x
P/E ratio 2025 *
61.2 x
Employees -
Yield 2024 *
0.72%
Yield 2025 *
0.94%
Free-Float 28.27%
More Fundamentals * Assessed data
Dynamic Chart
1 day-6.33%
1 week-4.17%
Current month-1.90%
1 month-0.48%
3 months+2.99%
6 months+3.50%
Current year+1.97%
More quotes
1 week
200.00
Extreme 200
224.00
1 month
197.50
Extreme 197.5
224.00
Current year
181.00
Extreme 181
239.00
1 year
170.00
Extreme 170
239.00
3 years
165.00
Extreme 165
660.00
5 years
139.20
Extreme 139.2
660.00
10 years
39.90
Extreme 39.9
660.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 22-03-31
Director of Finance/CFO 58 Oct. 31
Director/Board Member 44 13-12-31
Members of the board TitleAgeSince
Director/Board Member 53 20-05-12
Chairman 60 15-03-31
Director/Board Member 62 17-05-03
More insiders
Date Price Change Volume
24-04-19 207 -6.33% 1,948
24-04-18 221 +0.45% 12
24-04-17 220 0.00% 32
24-04-16 220 -1.35% 68
24-04-15 223 +3.24% 181

Delayed Quote Nasdaq Stockholm, April 19, 2024 at 08:52 am EDT

More quotes
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings